Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Characteristics and Outcome of Patients with Core Binding Factor Acute Myeloid Leukemia and FLT3 -ITD: Results from an International Collaboration

Sabine Kayser, MD, Michelle A Elliott, MD, Marlise Luskin, MDMS, Andrew M. Brunner, MD, Michael Kramer, M.Sc., Zdenek Racil, MD, Zuzana Sustkova, MD, Petr Cetkovsky, MD MBA, PhD, Jan Novak, MD PhD, Friedrich Stoelzel, MD, Christian Thiede, MD, Carsten Müller-Tidow, MD, Uwe Platzbecker, Christoph Röllig, MD MSC, Richard F. Schlenk, MD, Mark J. Levis, MD

Blood (2019) 134 (Supplement_1): 2693.

https://doi.org/10.1182/blood-2019-125317

Published: 2019

Journal Articles

Interleukin 21 Enhances Survival and Expansion of CAR T Cells Via Inhibition of Their Terminal Differentiation during Interaction with Tumor Target Cells

Martin Štach, Jan Musil, Petr Cetkovsky, MD MBA, PhD, Pavel Otahal, MD PhD

Blood (2018) 132 (Supplement 1): 4545.

https://doi.org/10.1182/blood-2018-99-116294

Published: 2018

Journal Articles

An Analysis of Real Life Data Obtained from 30 Years Follow-up of Primary Myelodysplastic Syndromes (MDS) Patients Confirms a Leading Role of Stem Cell Transplantation (SCT) for Achievement of Prolonged Survival

Jaroslav Cermak, MD PhD, Antonin Vitek, MD, Dana Mikulenkova, MD, Jacqueline Soukupova, MD, Jana Brezinova, Marketa Stastna, MD PhD, Veronika Valkova, MD PhD, Monika Belickova, PhD, Kyra Michalova, PhD, Petr Cetkovsky, MD MBA, PhD

Blood (2018) 132 (Supplement 1): 4372.

https://doi.org/10.1182/blood-2018-99-114987

Published: 2018

Journal Articles

HLA Class I-Specific Effects in AML with Mutated Nucleophosmin

Kateřina Kuželová, PhD, Christoph Röllig, MD, Zdenek Racil, MD, Juliane S. Stickel, MD, Barbora Brodská, PhD, Johannes Schetelig, MD MSc, Christian Thiede, MD, Gerhard Ehninger, MD, Grzegorz Helbig, MD PhD, Slawomira Kyrcz-Krzemien, Prof, Jiri Mayer, Petr Cetkovsky, MD MBA, PhD

Blood (2016) 128 (22): 5230.

https://doi.org/10.1182/blood.V128.22.5230.5230

Published: 2016

Journal Articles

Immune Response in Acute Myeloid Leukemia with Mutated Nucleophosmin

Katerina Kuzelova, PhD, Barbora Brodská, PhD, Jana Marková, Grzegorz Helbig, MD PhD, Slawomira Kyrcz-Krzemien, MD PhD, Petr Cetkovsky, MD MBA, PhD

Blood (2015) 126 (23): 2572.

https://doi.org/10.1182/blood.V126.23.2572.2572

Published: 2015

NARROW

Characteristics and Outcome of Patients with Core Binding Factor Acute Myeloid Leukemia and FLT3 -ITD: Results from an International Collaboration

Interleukin 21 Enhances Survival and Expansion of CAR T Cells Via Inhibition of Their Terminal Differentiation during Interaction with Tumor Target Cells

An Analysis of Real Life Data Obtained from 30 Years Follow-up of Primary Myelodysplastic Syndromes (MDS) Patients Confirms a Leading Role of Stem Cell Transplantation (SCT) for Achievement of Prolonged Survival

HLA Class I-Specific Effects in AML with Mutated Nucleophosmin

Immune Response in Acute Myeloid Leukemia with Mutated Nucleophosmin

Email alerts

ASH Publications

American Society of Hematology

Characteristics and Outcome of Patients with Core Binding Factor Acute Myeloid Leukemia and FLT3 -ITD: Results from an International Collaboration

Interleukin 21 Enhances Survival and Expansion of CAR T Cells Via Inhibition of Their Terminal Differentiation during Interaction with Tumor Target Cells

An Analysis of Real Life Data Obtained from 30 Years Follow-up of Primary Myelodysplastic Syndromes (MDS) Patients Confirms a Leading Role of Stem Cell Transplantation (SCT) for Achievement of Prolonged Survival

HLA Class I-Specific Effects in AML with Mutated Nucleophosmin

Immune Response in Acute Myeloid Leukemia with Mutated Nucleophosmin

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only